Cell Therapy
GPAD-3 Study
ECCRI is currently recruiting subjects with documented peripheral arterial disease (PAD) for a clinical trial to determine if granulocyte-macrophage colony stimulating factor (GM-CSF) improves symptoms and blood flow in people with PAD. To learn more or to refer a patient call 470-421-4253 or email eccri@emory.edu.